NEW YORK, March 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p098235/Global-Biochips-Industry.html
This report analyzes the worldwide markets for Biochips in US$ Million by the following product segments - DNA Chips, Protein Chips, and Lab Chips. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Middle East, and Latin America. The report profiles 77 companies including many key and niche players such as Affymetrix, Agilent Technologies, Biomerieux, Bio-Rad Laboratories, Inc., Caliper Life Sciences, Cepheid Inc., GE Healthcare Ltd., Life Technologies Corporation, Ocimum Biosolutions Ltd., Takara Bio, Inc., Clontech Laboratories, Inc., and Zyomyx. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
A. DNA Chips 3
B. Protein Chips 4
C. Lab Chips 4
2. INDUSTRY OVERVIEW 5
A Primer 5
Recession Dries Up Funds for Biotech Firms 5
Promising Biochips Promote Biological Research 6
Current and Future Analysis 7
Key Forces Driving the Industry 7
DNA Chips Lead the Application Front 7
Protein Biochips - Set for Robust Expansion 8
Lab-on-a-Chips: Fusion of Nanotechnology & Genetic Engineering 8
Industry Challenges 9
Standardization: A Key Challenge 9
Price Dearness Pauses Biochips Growth 9
3. MARKET DYNAMICS 10
Current Approaches to Biochips 10
The Business of Biochips 10
Technological Differentiation in Demand 11
Focus on Highly Intelligent Diagnostic Systems 11
Scalability & Pricing - Focus Areas 11
Biochips: Expanding Role in Diagnostic Medicine 12
Advancements in Biochip Technology 12
Biochip Technology Boosts Personalised Medicine 13
Biochip Technology Spreads beyond Pharma Industry 13
Proteomics "Chip" into Biochip Technology 14
Towards Increasing Minaturization 14
Technological Trends 14
Sensitivity 14
Microfabrication 14
Density 15
Integrated Chips 15
Patent Trends 15
Table 1: Number of Lab-on-a-Chip Patents (includes
corresponding Graph/Chart) 15
Table 2: % of Lab-on-a-Chip Patent Documents by
Country/Authority of Origin (January 2008 - April 2009)
(includes corresponding Graph/Chart) 16
Table 3: Number of Lab-on-a-Chip Documents by Patent
Assignees (January 2008 - April 2009) (includes
corresponding Graph/Chart) 16
Patent Applications 17
4. COMPETITION 18
Industry Structure 18
Major Participants 18
Affymetrix: A Major Market Player 18
Other Market Players 19
Growing Partnerships between Pharma and Biotech Companies 19
Tech Giants Join the Biochip Fray 20
5. PRODUCT OVERVIEW 21
Biochips - Complex Blend of Biochemistry and Electronics 21
Historical Perspective 21
Lab-on-a-chip: An Enabled Technology 23
Utility 23
Evolution and Segmentation 23
Differing Perspectives 23
Classification of Biochips 24
Need for Biochips 25
Manufacturing Systems Used in Biochip Manufacture 25
Working of a Biochip 26
DNA Transcription & Translation Through A Biochip 26
A Functional Model 26
Cocktail of Disparate Technically Specialized Applications 27
Biochips: By-product of Multi-disciplinary Sciences 27
Nanotechnology 27
BioMEMS 27
Microfluidics 28
Micro Total Analysis System 28
6. BIOCHIP AND MICROARRAY CONSTRUCTION 30
Chip Architecture 30
Essence of a Biochip 30
Concept of a Microarray 30
Microarray Modules 30
High Degree of Automation Spurs Biochips Use 31
Microfabrication Technology in Biochips made from Polymer and
Plastics 31
Micro-optics in Biochips 32
Liquid Handling Through Micro-Dispensers 32
Capillary Electrophoresis and Electrochemical Detectors 32
Other Technologies 32
Management of Bio-information 32
Scanning 33
Microarray Database Management 33
Classification of DNA Chips 33
General Description of Spotted cDNA Microarrays 33
Spotted DNA Arrays 34
Spotted cDNA Versus Spotted Oligonucleotide Arrays 34
Limitations of Conventional cDNA Microarrays 34
Protein Biochips 35
General Applications of Protein Biochips 35
Challenges in the Design of a Protein Biochip 36
Limitations of Protein Chip Technology 36
Concluding Remarks for Protein Biochips 37
7. APPLICATIONS OF BIOCHIPS 38
Biochip Uses 39
Pharmaceutical Investigation 39
Medical Diagnostics 39
Advantages of Biosensor Chip Technology 40
Forensics 40
Transplantation Screening 40
Identity Testing 40
Water and Environmental Testing 41
Food Industry 41
8. PRODUCT INNOVATIONS AND DEVELOPMENTS 42
Randox Launches Evidence Evolution Analyzer 42
South Korea Develops Instant Microfluidic Biochip 42
Fluidigm Introduces Reusable FR48.48 Dynamic Array™ IFC 42
Cellix Introduces Vena4Y™ and Vena4Y2™ Biochips 42
Agilent Technologies Unveils Workflow HPLC-Chip 43
Febit Holding Introduces First Human Cancer Biochip 43
Blue4Green Rolls Out Lab-on-a-chip Solution 44
Randox Laboratories Unveils Biochip Arrays 44
Randox Laboratories Introduces Evidence Investigator 44
Randox Unveils Innovative DoA Biochips for Rapid Drug Screening 45
Randox Launches Revolutionary Biochip Analyser for Multiple
Cardiac Testing 45
Febit Unveils Biochip for DNA/RNA Detection and Enrichment on
Mouse Genome 46
Veredus Laboratories Launches Portable Test Kit for H1N1 Flu 46
Randox Develops Multi Marker Cardiac Biochip Array for MI
Diagnosis 46
VigeneTech and CapitalBio Launch Completely Integrated
Microarray Solution Platform 47
9. PRODUCT INNOVATIONS/DEVELOPMENTS IN THE RECENT PAST - A
PERSPECTIVE BUILDER 48
Randox Introduces New Biochip Array for CAMs Testing 48
Cellix Announces Global Launch of VenaEC Biochip 48
Decision Biomarkers Rolls Out AVANTRA™ Biomarker Workstation
System 48
Osaka Develops Biocompatible Monomers for Biochips 49
Iris BioTechnologies Launches New Nano-Biochip 49
Affymetrix Introduces Complete Cytogenetic Solution 49
Agilent Unveils 244K CGH Micro-Array 50
Randox Unveils World's First Protein Biochip 50
Randox Introduces Thyroid Array Biochip 50
Sigma Launches ChIP Kit 51
Randox Develops Biochip for Synthetic Steroids 51
US and Czech Scientists to Develop Biochips for Detecting Cancer 51
Manchester University Researchers Develop New Protein Chips
Manufacturing Procedure 51
febit Introduces New Geniom Biochip 52
Agilent Introduces Additions to the HPLC-Chip Line for Proteomics 53
Progenika Develops BLOODchip 53
Roche Introduces Gene Expression Services and Arrays 53
Stratos Biosystems Develops New EC-Affinity Biochips 54
Affymetrix Unveils Affymetrix GeneChip Command Console Software 54
Affymetrix Introduces GeneChip Mouse and Rat Gene 1.0 ST Arrays 55
Affymetrix Unveils Genome-Wide Human SNP Array 6.0 55
Caliper Life Sciences Launches High Throughput RNA Assay 55
Applied Biosystems Unveils DNA Tools 56
febit Launches Geniom RT Analyzer 56
Austrian Research Center Develops New Biochip Surface 57
Researchers Develop Biochips to Eliminate Animal Testing 57
Progenika Biopharma Launches IBD DNA 57
Bioident Develops New Lab-on-a-Chip Nanotiter Plate Prototype 57
Ilochip and University of Denmark Develop a Biochip for Faster
Bird Flu Detection 58
CombiMatrix Develops a Biochip for Leukemia Analysis 58
Affymetrix Launches New Tiling Arrays for Mapping Whole-Genome
Transcript 58
Roche Plans to Launch AmpliChip in Japan 59
Caliper Life Sciences Unveils Desktop Profiler 59
Massachusetts Institute of Technology Develops Portable Lab on
a Chip 59
Optical Device to Develop Lab-on-a-Chip 59
Agilent Launches Five New HPLC Chips 60
Protagen AG Launches New Protein Biochips 60
Fluidigm Releases the 8.96 TOPAZ Screening Chip 60
Affymetrix Releases Chip-on-Chip Array 60
DNA Chip Research Launches High Sensitivity DNA Chip 60
DNA Chip Research and HitachiSoft Unveils AceGene 60
10. RECENT INDUSTRY ACTIVITY 61
Philips and bioMerieux to Produce Biochips for Cardiovascular
Assays 61
Roche Diagnostics and CapitalBio to Sign MOU 61
SVTC Partners with TSMC to Commercialize New Technologies 61
HORIBA Jobin Yvon Takes Over GenOptics 62
GWC Technologies to Receive $100,000 Federal Grant 62
febit to Receive Funds for Biomarker Project 62
Researchers Assess TB-Biochip MDR Test System 63
IBM to Use DNA Chip for Developing Personalized Medicine 63
11. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER 64
Invitrogen and Applied Biosystems Merge to Form Life
Technologies Corporation 64
China Medical Technologies Signs Agreement with Molecular
Diagnostics Technologies 64
DNA Chip Acquires HuBit's Gene Analysis Business 64
Affymetrix Acquires USB 65
Roche NimbleGen Forms Alliance with BioDiscovery to Provide
CGH Solutions 65
Illumina Announces Partnership with Genpathway for ChIP
Sequencing Services 65
Jiangsu and IMDi Diagnosis to Establish Joint Venture 66
Plexera Biosciences Enters into an Option Deal with Auguron 66
Affymetrix and Avesthagen Enter into an Agreement 67
Roche NimbleGen and Affymetrix Announce Expansion of License
Agreement 67
Proteomika and Auguron Biosciences Ink Option Agreement 67
Gentel Biosciences and Eppendorf Enter into Global License
Agreement 68
GATC Biotech Establishes New Subsidiary 68
Procognia Spins off Sense Proteomic 69
Johns Hopkins University Purchases MassARRAY System 69
Yale University Purchases MassARRAY System 69
Korea's NIH Extends KARE Project with Affymetrix Technology 69
febit Obtains US Patent for Hybselect, a Microfluidic
Extraction Method 70
Atotech Enters into Research Collaboration with University of
Albany 70
CapitalBio and Beijing National Engineering Research Center
Develop New Biochip Testing System 70
Roche Takes Over NimbleGen 71
GenTel BioSciences Acquires Protein Chip Platform Assets of GSK 71
Advanced Liquid Logic Acquires Nanolytics 72
Applied Microarrays Acquires Select GE Healthcare's Assets 72
Canon, Toshiba and Other Companies to Join Hands for Biochips 73
BioChip Innovations Signs Research Collaboration Agreement
with IME 73
Protagen Enters into a Partnership to Develop Antibodies 73
Spanish Society of Rheumatology Enters into Collaboration with
Progenika 74
Affymetrix and Partners Healthcare Extend Collaboration 74
Agencourt, NuGEN and Affymetrix Clinical Services Collaborate 74
Affymetrix Inks Licensing Agreement with Empire Genomics 75
Caliper Enters into a Licensing Agreement with Monogram
Biosciences 75
Affymetrix and IPSOGEN Sign Agreement 76
bioMérieux and NuGEN Enter into Supply and Cross-License
Agreement 76
VWR and CapitalBio Enter into a Distribution Agreement 77
C3B Bags Contract from Department of Defense to Develop an
Implantable Biochip 77
UCL Subsidiary and Roche Diagnostics Ink Licensing Deal 77
Affymetrix Establishes the European Cytogenetic Research
Initiative 78
Fluidigm Establishes New Development Center 78
Daiichi Pure Chemicals Applies for Approval to Market DNA
Micro-array 78
GE Healthcare Snaps Up Biacore 79
Bio-Rad Acquires Ciphergen's Life Science Research Business 79
Sysmex to Form Partnership with Affymetrix 79
Daiichi, Toshiba Hokuto and Toshiba Join Hands 79
Affymetrix Collaborates with Zhejiang California Nanosystem
Institute 80
Merck Sharp & Dohme and Shanghai Biochip Enter into Co-
operation Agreement 80
Toshiba Signs Licensing Agreement with Antara BioSciences 81
MUSC Signs LOI with Lumera 81
AVIVA Inks Agreement with Japan's Cosmo Bio 81
Lumera Signs Collaborative Agreement with Harvard Medical School 81
Whatman Receives CE Mark for CombiChip 82
IDIBAPS Led Project Receives Approval from European Union 82
Toray to Establish DNA Chip Business 83
Protagen Forays into the US Market 83
Biacore Expands Operations into Chinese Market 83
Nisshinbo to Replace Glass with Resin in DNA Production 83
12. FOCUS ON SELECT GLOBAL PLAYERS 84
Affymetrix Inc (US) 84
Agilent Technologies, Inc. (US) 84
Biomerieux SA (France) 85
Bio-Rad Laboratories, Inc. (US) 85
Caliper Life Sciences, Inc. (US) 85
Cepheid Inc. (US) 86
GE Healthcare Ltd. (UK) 86
Life Technologies Corporation (US) 86
Ocimum Biosolutions Ltd. (India) 87
Takara Bio, Inc. (Japan) 87
Clontech Laboratories, Inc. (US) 88
Zyomyx Inc (US) 88
13. GLOBAL MARKET PERSPECTIVE 89
Table 4: World Recent Past, Current & Future Analysis for
Biochips by Geographic Region - US, Canada, Japan, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 89
Table 5: World Historic Review for Biochips by Geographic
Region - US, Canada, Japan, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 90
Table 6: World 11-Year Perspective for Biochips by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Canada,
Japan, Europe, and Rest of World Markets for Years 2005, 2010&
2015 (includes corresponding Graph/Chart) 91
Table 7: World Recent Past, Current & Future Analysis for DNA
Chips by Geographic Region - US, Canada, Japan, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 92
Table 8: World Historic Review for DNA Chips by Geographic
Region - US, Canada, Japan, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 93
Table 9: World 11-Year Perspective for DNA Chips by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Canada,
Japan, Europe, and Rest of World Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 94
Table 10: World Recent Past, Current & Future Analysis for
Protein Chips by Geographic Region - US, Canada, Japan,
Europe, and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 95
Table 11: World Historic Review for Protein Chips by
Geographic Region - US, Canada, Japan, Europe, and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 96
Table 12: World 11-Year Perspective for Protein Chips by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, and Rest of World Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart) 97
Table 13: World Recent Past, Current & Future Analysis for Lab
Chips by Geographic Region - US, Canada, Japan, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 98
Table 14: World Historic Review for Lab Chips by Geographic
Region - US, Canada, Japan, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 99
Table 15: World 11-Year Perspective for Lab Chips by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, and Rest of World Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart) 100
14. THE UNITED STATES 101
A.Market Analysis 101
Outlook 101
An Insight into Biochip Products & Services Market 101
Rapid Growth for Protein, Lab Biochips 101
Robust Demand for Biochip Reagents and Consumables 102
Growth Prospects for Biochip Instruments & Software 102
Potential for Biochip Service Revenues 103
Biochip Product & Service Demand Among Biotech Companies 103
Biochip Products and Services Demand in Life Science
Research Applications 103
Laboratory Chips Market 104
Table 16: US Laboratory Chip Market by Application (2007 &
2015P): Percentage Share Breakdown of Revenues for Life
Science Research, Forensic Medicine, In Vitro Diagnostic
Testing, Drugs-of- Abuse Testing, Disease Management, and
Others (includes corresponding Graph/Chart) 104
Competitive Landscape 105
Table 17: Leading Players in the US Biochip Products and
Services Market (2007): Percentage Share Breakdown of
Revenues for Illumina, Affymetrix, Applied Biosystems,
GE/Amersham, Invitrogen, Bio-Rad, Caliper Life Science,
Cepheid, Agilent Techs, Beckman Coulter, and Others
(includes corresponding Graph/Chart) 105
B.Market Analytics 106
Table 18: US Recent Past, Current & Future Analysis for
Biochips by Product Segment - DNA Chips, Protein Chips and
Lab Chips Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 106
Table 19: US Historic Review for Biochips by Product Segment-
DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 106
Table 20: US 11-Year Perspective for Biochips by Product
Segment - Percentage Breakdown of Dollar Sales for DNA
Chips, Protein Chips and Lab Chips Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 107
15. CANADA 108
Market Analysis 108
Table 21: Canadian Recent Past, Current & Future Analysis
for Biochips by Product Segment - DNA Chips, Protein Chips
and Lab Chips Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 108
Table 22: Canadian Historic Review for Biochips by Product
Segment - DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 109
Table 23: Canadian 11-Year Perspective for Biochips by
Product Segment - Percentage Breakdown of Dollar Sales for
DNA Chips, Protein Chips and Lab Chips Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart) 109
16. JAPAN 110
A.Market Analysis 110
Outlook 110
ICAN ™ Technology for Large-Scale Production of DNA Fragments 110
B.Market Analytics 111
Table 24: Japanese Recent Past, Current & Future Analysis
for Biochips by Product Segment - DNA Chips, Protein Chips
and Lab Chips Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 111
Table 25: Japanese Historic Review for Biochips by Product
Segment - DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 112
Table 26: Japanese 11-Year Perspective for Biochips by
Product Segment - Percentage Breakdown of Dollar Sales for
DNA Chips, Protein Chips and Lab Chips Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart) 113
17. EUROPE 114
A.Market Analysis 114
Outlook 114
Lab-on-chip Market in Europe 114
European Advancements Shape Diagnostic Procedures 115
B.Market Analytics 116
Table 27: European Recent Past, Current & Future Analysis
for Biochips by Geographic Region - France, Germany, UK, and
Rest of Europe Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 116
Table 28: European Historic Review for Biochips by
Geographic Region - France, Germany, UK, and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 117
Table 29: European 11-Year Perspective for Biochips by
Geographic Region - Percentage Breakdown of Dollar Sales for
France, Germany, UK, and Rest of Europe Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart) 118
Table 30: European Recent Past, Current & Future Analysis
for Biochips by Product Segment - DNA Chips, Protein Chips
and Lab Chips Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 119
Table 31: European Historic Review for Biochips by Product
Segment - DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 120
Table 32: European 11-Year Perspective for Biochips by
Product Segment - Percentage Breakdown of Dollar Sales for
DNA Chips, Protein Chips and Lab Chips Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart) 121
17a. FRANCE 122
Market Analysis 122
Table 33: French Recent Past, Current & Future Analysis for
Biochips by Product Segment - DNA Chips, Protein Chips and
Lab Chips Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 122
Table 34: French Historic Review for Biochips by Product
Segment - DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 123
Table 35: French 11-Year Perspective for Biochips by Product
Segment - Percentage Breakdown of Dollar Sales for DNA
Chips, Protein Chips and Lab Chips Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 124
17b. GERMANY 125
A.Market Analysis 125
Outlook 125
Berlin, Brandenburg and Biochips 125
B.Market Analytics 126
Table 36: German Recent Past, Current & Future Analysis for
Biochips by Product Segment - DNA Chips, Protein Chips and
Lab Chips Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 126
Table 37: German Historic Review for Biochips by Product
Segment - DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 127
Table 38: German 11-Year Perspective for Biochips by Product
Segment - Percentage Breakdown of Dollar Sales for DNA
Chips, Protein Chips and Lab Chips Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 128
17c. THE UNITED KINGDOM 129
Market Analysis 129
Table 39: UK Recent Past, Current & Future Analysis for
Biochips by Product Segments- DNA Chips, Protein Chips and
Lab Chips Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 129
Table 40: UK Historic Review for Biochips by Product Segment-
DNA Chips, Protein Chips and Lab Chips Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 130
Table 41: UK 11-Year Perspective for Biochips by Product
Segment - Percentage Breakdown of Dollar Sales for DNA
Chips, Protein Chips and Lab Chips Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 131
17d. REST OF EUROPE 132
Market Analysis 132
Table 42: Rest of Europe Recent Past, Current & Future
Analysis for Biochips by Product Segment - DNA Chips,
Protein Chips and Lab Chips Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 132
Table 43: Rest of Europe Historic Review for Biochips by
Product Segment - DNA Chips, Protein Chips and Lab Chips
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 133
Table 44: Rest of Europe11-Year Perspective for Biochips by
Product Segment - Percentage Breakdown of Dollar Sales for
DNA Chips, Protein Chips and Lab Chips Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart) 134
18. REST OF WORLD 135
A.Market Analysis 135
Outlook 135
China 135
Basic Environment and Commercial Development 135
Biochip Research Institutes 136
Taiwan 136
Taiwan Pursues Promise of Biochip Sector 136
International Advantage Sought 137
B.Market Analytics 138
Table 45: Rest of World Recent Past, Current & Future
Analysis for Biochips by Product Segment - DNA Chips,
Protein Chips and Lab Chips Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 138
Table 46: Rest of World Historic Review for Biochips by
Product Segment - DNA Chips, Protein Chips and Lab Chips
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 139
Table 47: Rest of World 11-Year Perspective for Biochips by
Product Segment - Percentage Breakdown of Dollar Sales for
DNA Chips, Protein Chips and Lab Chips Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart) 140
COMPETITIVE LANDSCAPE
Total Companies Profiled: 77 (including Divisions/Subsidiaries - 87)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 40
Japan 14
Europe 24
France 4
Germany 8
The United Kingdom 4
Spain 1
Rest of Europe 7
Asia-Pacific (Excluding Japan) 9
------------------------------------------
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article